Global Pharmaceuticals & Biotech Big Green Snowflakes

hVIVO

Market Cap: UK£38.5m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Santen Pharmaceutical

Market Cap: JP¥514.4b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Merck

Market Cap: Rp1.4t

Engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally.

Xiamen Amoytop Biotech

Market Cap: CN¥31.8b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

Earth Science Tech

Market Cap: US$49.7m

Together with its subsidies, focuses on health and wellness industry.

Beit Jala Pharmaceutical

Market Cap: د.أ22.5m

Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.

Beximco Pharmaceuticals

Market Cap: ৳49.7b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

Torrent Pharmaceuticals

Market Cap: ₹1.3t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

Jacobson Pharma

Market Cap: HK$2.7b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

Pfizer

Market Cap: ₹227.6b

Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

Alivus Life Sciences

Market Cap: ₹110.2b

Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥44.2b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.

WuXi Biologics (Cayman)

Market Cap: HK$128.3b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹277.3b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

Tong Ren Tang Technologies

Market Cap: HK$6.1b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Harmony Biosciences Holdings

Market Cap: US$2.0b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Hoechst Pakistan

Market Cap: PK₨40.5b

Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.

Vikram Thermo (India)

Market Cap: ₹5.4b

Engages in the manufacture, marketing, and export of pharmaceutical excipients and chemicals in India and internationally.

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥30.3b

Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.

Zhejiang CONBA PharmaceuticalLtd

Market Cap: CN¥11.7b

Engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China.

Memphis Pharmaceuticals & Chemical Industries

Market Cap: ج.م3.8b

A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.

Oncodesign Precision Medicine Société anonyme

Market Cap: €8.0m

A biopharmaceutical company, engages in the precision medicine business.

Hikma Pharmaceuticals

Market Cap: UK£3.4b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Johnson & Johnson

Market Cap: US$498.5b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Merck KGaA

Market Cap: €50.4b

Operates as a science and technology company in Germany and internationally.

Catalyst Pharmaceuticals

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Bora Pharmaceuticals

Market Cap: NT$67.8b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Central Pharmaceutical No3

Market Cap: ₫1.1t

Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.

Square Pharmaceuticals

Market Cap: ৳181.3b

Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.

Blue Jet Healthcare

Market Cap: ₹100.3b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

CSL

Market Cap: AU$90.0b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Duopharma Biotech Berhad

Market Cap: RM 1.2b

An investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.

Grifols

Market Cap: €6.4b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Novo Nordisk

Market Cap: DKK 1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Gilead Sciences

Market Cap: US$156.1b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

ADMA Biologics

Market Cap: US$4.6b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.